Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media

Cited by (158)

Items 101–158 of 158

1. Evaluation of a novel oxiconazole nitrate formulation: The thermosensitive gel
   Alper Arslan, Cansel Köse Özkan, Ali Korhan Sığ, Eyup Dogan, Özgür Eşi̇m, Serdar Çetinkaya, Filiz Atalay, Çetin Taş, Ayhan Savaşer, Yalçın Özkan · 2018 · Saudi Pharmaceutical Journal
2. Sequencing of FKS Hot Spot 1 from Saprochaete capitata To Search for a Relationship to Reduced Echinocandin Susceptibility
   Inés Arrieta-Aguirre, Pilar Menéndez-Manjón, María Soledad Cuétara, Íñigo Fernandez-de-Larrinoa, Juan Carlos García‐Ruiz, Maria Dolores Moragues · 2017 · Antimicrobial Agents and Chemotherapy
3. The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods
   Ben-Ami, Ronen, Hilerowicz, Yuval, Novikov, Anna, Giladi, Michael · 2014 · Diagnostic Microbiology and Infectious Disease
4. Multicentre Surveillance of Candida Species from Blood Cultures during the SARS-CoV-2 Pandemic in Southern Europe (CANCoVEU Project)
   Matteo Boattini, Margarida Feijó Pinto, Eirini Christaki, Teresa Fasciana, Iker Falces‐Romero, Andreas G. Tofarides, Gabriele Bianco, Emilio Cendejas‐Bueno, Maria Rita Tricoli, Giorgos Tsiolakkis et al. · 2023 · Microorganisms
5. The association between treatment appropriateness according to EUCAST and CLSI breakpoints and mortality among patients with candidemia: a retrospective observational study
   Nesrin Ghanem‐Zoubi, Danny Zorbavel, Johad Khoury, Yuval Geffen, Majd Qasum, Svetlana Predescu, Mical Paul · 2018 · European Journal of Clinical Microbiology & Infectious Diseases
6. In Vitro Antifungal Effect of Acrylic Corneal Glue (N-Butyl-2-Cyanoacrylate)
   Cezmi Doğan, Gökhan Aygün, Hrisi Bahar Tokman, Zeynep Yazgan, Burak Mergen, Akif Özdamar, Osman Şevki Arslan · 2019 · Cornea
7. Antifúngicos en el tratamiento de las infecciones sistémicas: importancia del mecanismo de acción, espectro de actividad y resistencias
   Manuel Cuenca‐Estrella · 2010 · Revista española de quimioterapia. Suplemento
8. The effect of aqueous and ethanolic extract of Iranian propolis on Candida Albicans isolated from the mouth of patients with colorectal malignancy undergone chemotherapy: An in-vitro study.
   Fatemeh Sayyadi, Saeed Mahdavi, Ali Akbar Moghadamnia, Dariush Moslemi, Atena Shirzad, Mina Motallebnejad · 2020 · Europe PMC (PubMed Central)
9. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections
   Effie L. Kuti, Joseph L. Kuti · 2010 · Expert Opinion on Drug Metabolism & Toxicology
10. Wild-type MIC distributions and epidemiological cutoff values for 5-flucytosine and Candida species as determined by EUCAST broth microdilution
    Fatima Zohra Delma, Willem J. G. Melchers, Paul E. Verweij, Jochem B. Buil · 2024 · JAC-Antimicrobial Resistance
11. Antifungal Drug Susceptibility and Genetic Characterization of Fungi Recovered from COVID-19 Patients
    Milena Kordalewska, Kevin D. Guerrero, Rocio Garcia‐Rubio, Cristina Jiménez‐Ortigosa, José R. Mediavilla, Marcus H. Cunningham, Frank Hollis, Tao Hong, Kar Fai Chow, Barry N. Kreiswirth et al. · 2021 · Journal of Fungi
12. In vitro activity of echinocandins against non-Candida albicans: Is echinocandin antifungal activity the same?
    Ana Espinel‐Ingroff, Emilia Cantón · 2011 · Enfermedades Infecciosas y Microbiología Clínica
13. Development and preliminary validation of a modified EUCAST yeast broth microdilution MIC method with Tween 20-supplemented medium for rezafungin
    Douglas E. Zuill, Amanda L. Almaguer, Joanna L. Donatelli, Maiken Cavling Arendrup, Jeffrey B. Locke · 2023 · Journal of Antimicrobial Chemotherapy
14. New antifungal agents for the treatment of candidaemia
    Patricia Muñóz, Jesús Guinea, Loreto Rojas, Emilio Bouza · 2010 · International Journal of Antimicrobial Agents
15. Antifungal effect of tea extracts on Candida albicans
    Jing-jing HUANG, Hao YU, Guang Hong, Hui Dong Cheng, Ming Zheng · 2020 · Dental Materials Journal
16. Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin
    Marie‐Elisabeth Bougnoux, Éric Dannaoui, Isabelle Accoceberry, A. Angoulvant, E. Bailly, Françoise Botterel, S. Chevrier, Taïeb Chouaki, Muriel Cornet, Frédéric Dalle et al. · 2016 · Antimicrobial Agents and Chemotherapy
17. EUCAST Ibrexafungerp MICs and Wild-Type Upper Limits for Contemporary Danish Yeast Isolates
    Karin Meinike Jørgensen, Karen Marie Thyssen Astvad, Rasmus Krøger Hare, Maiken Cavling Arendrup · 2022 · Journal of Fungi
18. Caspofungin MIC Distribution amongst Commonly Isolated Candida Species in a Tertiary Care Centre - An Indian Experience
    Shashir Wanjare · 2016 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
19. Influence of Serum and Albumin on Echinocandin In Vitro Potency and Pharmacodynamics
    Aasya Nasar, Laurajo Ryan, Christopher Raymond Frei, Jason M. Cota, Nathan P. Wiederhold · 2013 · Current Fungal Infection Reports
20. Susceptibility Screening of Hyphae-Forming Fungi with a New, Easy, and Fast Inoculum Preparation Method
    A. Schmalreck, Birgit Willinger, Viktor Alexander Czaika, W. Fegeler, Karsten Becker, Gerhard Blum, Cornelia Lass‐Flörl · 2012 · Mycopathologia
21. Mechanisms of Resistance to Antifungal Agents
    Theodore C. White, Samantha J. Hoot · 2011 · Wiley eBooks
22. Malassezia species: the need to establish epidemiological cutoff values
    Florencia Dinorah Rojas, María de los Ángeles Sosa, Wenceslao Latorre, Javier Esteban Mussin, Liliana Alegre, Gustavo Giusiano · 2022 · Medical Mycology
23. Should Etest MICs for Yeasts Be Categorized by Reference (BPs/ECVs) or by Etest (ECVs) Cutoffs as Determinants of Emerging Resistance?
    Ana Espinel‐Ingroff, Éric Dannaoui · 2020 · Current Fungal Infection Reports
24. Prévalence de Candida parapsilosis, C. orthopsilosis et de C. metapsilosis au sein des candidémies au CHU de Nantes et profil de sensibilité aux échinocandines par la méthode E-test® : étude rétrospective de cinq ans (2004–2009)
    G. Thierry, Florent Morio, Patrice Le Pape, Françoise Gay‐Andrieu, O. Barre, Michel Miegeville · 2010 · Pathologie Biologie
25. Role of CgTpo4 in Polyamine and Antimicrobial Peptide Resistance: Determining Virulence in Candida glabrata
    Mafalda Cavalheiro, Daniela Romão, Rui Santos, Dalila Mil‐Homens, Pedro Pais, Catarina Costa, Mónica Galocha, Diana Pereira, Azusa Takahashi‐Nakaguchi, Hiroji Chibana et al. · 2021 · International Journal of Molecular Sciences
26. Comparison of Caspofungin MICs by Means of EUCAST Method EDef 7.1 Using Two Different Concentrations of Glucose
    Juan L. Rodrı́guez-Tudela, Alicia Gómez‐López, Maiken Cavling Arendrup, Guillermo García‐Effrón, David S. Perlin, Cornelia Lass‐Flörl, Manuel Cuenca‐Estrella · 2010 · Antimicrobial Agents and Chemotherapy
27. Evaluation of Inoculum Preparation for Etest and EUCAST Broth Dilution to Detect Anidulafungin Polyresistance in Candida glabrata
    Miriam Alisa Knoll, Eldina Samardzic, Wilfried Posch, Cornelia Lass‐Flörl · 2022 · Antimicrobial Agents and Chemotherapy
28. What Is the Target? Clinical Mycology and Diagnostics
    Birgit Willinger · 2018 · Springer eBooks
29. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii
    Zeynep Sarıbaş, Pınar Yurdakul, Gulsen Cetin‐Hazirolan, Sevtap Arıkan-Akdağlı · 2011 · Mycoses
30. Emerging Resistance to Azoles and Echinocandins: Clinical Relevance and Laboratory Detection
    Ana Espinel‐Ingroff, Michael A. Pfaller, Emilia Cantón, Javier Pemán · 2010 · Current Fungal Infection Reports
31. Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?
    Roya Vahedi‐Shahandashti, Eleonora Moroder, Cornelia Lass‐Flörl · 2025 · Antimicrobial Agents and Chemotherapy
32. Candidiasis invasora en un receptor de trasplante hepático: tratamiento antifúngico de rescate precoz
    Juan Carlos Pozo Laderas, y Antonio Pontes-Moreno · 2011 · Revista Iberoamericana de Micología
33. Effectiveness of Zornia diphylla (L.) Pers. against fungal diseases
    R Arunkumar, S. Ajikumaran Nair, Appian Subramoniam, Tropical Botanic · 2012
34. Definitions and Epidemiology of Candida Species not Susceptible to Echinocandins
    Michael A. Pfaller, Daniel J. Diekema, Mariana Castanheira, Ronald N. Jones · 2011 · Current Fungal Infection Reports
35. Echinocandins
    Andreas H. Groll, Dominik Schrey, Thomas J. Walsh · 2010 · Springer eBooks
36. In vitro activity of echinocandins against 562 clinical yeast isolates from a Romanian multicentre study
    Mihai Mareș, Bogdan Minea, Valentin Năstasă, Irina Roșca, Andra-Cristina Bostănaru, Iosif Marincu, Vasilica Toma, Violeta Corina Cristea, Carmen Murariu, Mariana Pinteală · 2017 · Medical Mycology
37. Advances in Antifungal Susceptibility Testing of Candida, 2010–2012
    Michael A. Pfaller, Mariana Castanheira, Ronald N. Jones · 2012 · Current Fungal Infection Reports
38. The prevalence and clinical significance of microcolonies when tested according to contemporary interpretive breakpoints for fluconazole against Candida species using E-test
    Michael Hauzer, Matan Joel Cohen, Itzhack Polacheck, Allon E. Moses, Maya Korem · 2018 · Medical Mycology
39. Sensibilidad de aislamientos de Candida albicans de hemocultivos a 3 fármacos: estudio retrospectivo en Rio Grande do Sul, Brasil, 1999 a 2009
    Antonella Souza Mattei, Sydney Hartz Alves, Débora Alves Nunes Mario, Guilherme Watte, Cecília Bittencourt Severo, Luciana Silva Guazzelli, Flávio de Mattos Oliveira, Luiz Carlos Severo · 2013 · Revista Iberoamericana de Micología
40. Fungal Drug Resistance Assays
    Sevtap Arıkan, John H. Rex · 2009 · Humana Press eBooks
41. Fungal Drug Resistance Assays
    Sevtap Arıkan-Akdağlı, John H. Rex · 2017 · Springer eBooks
42. Role of ERG11 and MDR1 genes in cycloheximide and multidrug resistance in Candida species
    Zill-e- Huma, Sidrah Saleem, Muhammad Imran, Syed Mohsin Raza, Kokab Jabeen, Faiqa Arshad · 2024 · Brazilian Journal of Microbiology
43. Wild-type MIC distributions and epidemiological cut-off values for ibrexafungerp, manogepix, and rezafungin against WHO fungal priority pathogens
    Maria J. Morelo, Carolina Firacative, Guillermo García‐Effrón, Beatriz L. Gómez, Andrés Ceballos-Garzón · 2026 · International Journal of Antimicrobial Agents
44. Comparison of CLSI broth macrodilution and microdilution methods for echinocandin susceptibility testing of 5 Candida species
    Lawrence H. Bopp, Aldona L. Baltch, William J. Ritz, Raymond P. Smith · 2011 · Diagnostic Microbiology and Infectious Disease
45. Yeasts
    Sean X. Zhang, Nathan P. Wiederhold · 2016 · Microbiology Spectrum
46. Epidemiology of Candidemia in Finland
    Eira Poikonen · 2011 · Työväentutkimus Vuosikirja
47. MIC Distributions and Epidemiological Cut-off Values for Azithromycin in Neisseria gonorrhoeae as Determined by Agar Dilution
    Kathryn Lupoli · 2022 · Digital Archive @ GSU
48. Perfil fenotípico, diferenciação molecular, produção de enzimas e sensibilidade aos antifúngicos de amostras de leveduras isoladas em três grupos amostrais: mulheres assintomáticas, com candidíase vulvovaginal primária e recorrente
    D. Moreira · 2012
49. Bifonazole in vitro activity and its azole-parallel resistance in clinical yeast isolates
    Viktor Alexander Czaika, H. J. Tietz, A. Schmalreck · 2014 · JOURNAL OF ADVANCES IN BIOLOGY
50. Echinocandin Resistance
    David S. Perlin · 2017 · Springer eBooks
51. Yeasts
    Sean X. Zhang, Nathan P. Wiederhold · 2016 · ASM Press eBooks
52. Detecting Echinocandin Resistance in C. glabrata Using Commercial Methods: Are CLSI or EUCAST Breakpoints Suitable for Categorical Classification?
    Pilar Escribano, Laura Alguacil Cuéllar, Almudena Álvarez‐Gutiérrez, Patricia Muñóz, Jesús Guinea · 2024 · Mycoses
53. Isavuconazole activity against Candida species from Brazil focusing on C. auris : MIC comparison between EUCAST and CLSI
    Bruna Rodrigues de Sousa, Camylla Carvalho de Melo, Manoel Marques Evangelista Oliveira, Sylvia Lemos Hinrichsen, Rossana de Aguiar Cordeiro, Reginaldo Gonçalves de Lima-Neto · 2025 · Future Microbiology
54. Galactofuranose biosynthesis is important for maintaining normal growth and cell wall properties in Aspergillus nidulans
    Kausar Alam · 2014 · University Library - University of Saskatchewan (University of Saskatchewan)
55. Six-month surveillance of Candida parapsilosis in Tyrol, Austria: high-risk ST11 lineage and early, heterogeneous fluconazole resistance
    Stephan Josef Maria Steixner, Roya Vahedi‐Shahandashti, David Eisele, Werner Ruppitsch, Cornelia Lass‐Flörl · 2026 · Frontiers in Cellular and Infection Microbiology
56. Evaluation of chemical composition and bioefficacy of Nepeta ciliaris Benth. essential oil
    Gunja Sah, Pooja Bargali, G.C. Shah, Ravendra Kumar, Stefanıa Garzoli, Maneesha pathak, Archana Negi Sah · 2026 · Next research.
57. Fatty acid synthase 1 in Candida albicans virulence and the in vitro effects of fluconazole, tetracycline in combinatorial therapy
    Marissa Mandy Rodrigues · 2012
58. Atividade antimicrobiana in vitro de extratos hidroetanólicos de Astronium sp incorporados ou não em sistemas nanoestruturados
    Bruna Vidal Bonifácio · 2014 · Americanae (AECID Library)